Search DrRajHealth

Saturday, October 17, 2020

NSSP Supports the COVID-19 Response | CDC

BioSecurity Measures Protecting Americans Since 2003, the Department of Homeland Security (DHS) manages the BioWatch program, the nation's first early warning network of sensors to detect a biological attack. Project BioShield, signed into law in 2004, is part of the strategy to defend against the threat of weapons of mass destruction. Its purpose is to improve the research, development, purchase, and availability of medical countermeasures against biological, chemical, radiological and nuclear attacks. The CDC coordinates and analyzes laboratory testing. The CDC also manages the National Syndromic Surveillance Program (NSSP), which promotes and advances development of a syndromic surveillance for the timely exchange of syndromic data. A syndrome is a set of medical signs and symptoms and collection of diseases that are not correlated with each other and often associated with a particular disease or disorder. Syndromic data are used to improve nationwide situational awareness and enhance responsiveness to hazardous events and disease outbreaks. Another program managed by the CDC is the BioSense Platform. This is a congressionally funded program launched in 2003 to support national emergency preparedness. It is an integrated national public health surveillance system for early detection and rapid assessment of bioterrorism-related events. In 2011, the program's focus was expanded to include situational awareness for all hazards (including outbreaks). The NSSP promotes a community of practice in which participants collaborate to advance the science and practice of syndromic surveillance. This community is made up of NSSP-funded recipients, nonfunded state and local jurisdictions, public health practitioners, CDC programs, other federal agencies, hospitals, health care professionals, and academic institutions that all contribute data to the BioSense Platform. The data provided to your local and state health departments is passed along to the BioSense Platform to be included in the NSSP database. #biosecurity #COVID19
from Rajesh Harrykissoon, MD

No comments:

Post a Comment